3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
188
Leukemia, Lymphocytic, Chronic, B-Cell
69
Myelodysplastic Syndromes
47
Recurrence
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Lymphoma, Mantle-Cell
20
Leukemia, Myelomonocytic, Chronic
19
Hematologic Neoplasms
14
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma, Non-Hodgkin
13
Lymphoma
13
Leukemia, Biphenotypic, Acute
13
Burkitt Lymphoma
13
Lymphoma, B-Cell, Marginal Zone
12
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
11
Neoplasms
10
Waldenstrom Macroglobulinemia
8
Myeloproliferative Disorders
8
Lymphoma, Follicular
8
Lymphoma, B-Cell
7
Neoplasm, Residual
6
Leukemia, Myeloid
5
Blastic Plasmacytoid Dendritic Cell Neoplasm
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
GATA2 Deficiency
4
Leukemia, Monocytic, Acute
3
Immunoglobulin Light-chain Amyloidosis
3
Interventions
Fulvestrant
125
Trastuzumab
114
Paclitaxel
113
Letrozole
108
pembrolizumab
79
pertuzumab
75
palbociclib
75
Capecitabine
72
Anastrozole
72
Cyclophosphamide
70
Carboplatin
67
abemaciclib
64
exemestane
63
Tamoxifen
63
ribociclib
60
trastuzumab deruxtecan
57
Surveys and Questionnaires
51
Specimen Handling
50
Radiotherapy
49
Docetaxel
49
Magnetic Resonance Spectroscopy
48
Blood Specimen Collection
40
olaparib
39
Standard of Care
36
Biopsy
33
sacituzumab govitecan
31
130-nm albumin-bound paclitaxel
31
Doxorubicin
30
Exercise
29
eribulin
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
venetoclax
×
1 year
×
Clear all
No trials found.